The New Liberation Way


Meet Our New CEO

“We’re entering into a new era for Liberation Way, one in which the organization’s purpose and mission will guide every action we take,” said Drew Rothermel, J.D, MBA, and new President & CEO of Liberation Way. “One of the most important components of moving forward is to invest in our resources for clinical excellence while building upon the outpatient model that has proven to be very successful in helping people recover from opiate addiction. I am deeply committed to increase the number of people that we can treat with uncompromised ethical standards and compliance to laws to put the health and safety of our patients and workers first.”

Andrew “Drew” Rothermel, J.D, MBA
President & CEO of Liberation Way

Fulcrum Equity Partners Acquires Majority Interest in Liberation Behavioral Health; Hires Drew Rothermel as CEO


As the new CEO of Liberation Way, I would like to introduce myself and share some of the latest facility updates with you. Over the past couple of months, we’ve overhauled both our clinical and compliance processes. When you consider referring patients to our addiction treatment facilities, we want you to base your recommendation on who and what we are today. Liberation Way has always offered a full continuum of care and reality-based addiction treatment. But now we’ve refocused our commitment to clinical excellence, quality, and compliance—spearheaded by a leadership team comprised of credentialed experts and proven leaders from major recovery facilities.
Here’s what you need to know about  the new Liberation Way


Newest Members of Our Leadership Team

Liberation Behavioral Health Appoints Bethany Kassar, MSW, LCSW, as Executive Director   

Liberation Way Appoints a Director of Quality